Navigation Links
AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call
Date:7/29/2010

ALISO VIEJO, Calif., July 29 /PRNewswire-FirstCall/ -- AVANIR Pharmaceuticals, Inc. (Nasdaq: AVNR) today announced that it will release unaudited fiscal third quarter financial results for the three and nine months ended June 30, 2010 before market open on Thursday, August 5, 2010.  Keith Katkin, President and Chief Executive Officer, Randall Kaye, M.D., Senior Vice President and Chief Medical Officer, and Christine Ocampo, Vice President, Finance, will host an investment community conference call that same day at 8:00 a.m. Pacific time / 11:00 a.m. Eastern time to discuss those results and answer questions.

Investors are invited to listen to the live webcast by visiting AVANIR's corporate website at www.avanir.com.  To listen to the live call, please go to AVANIR's website prior to the start of the call to register, download and install the necessary audio software.

An archived copy of the webcast will be available on AVANIR's website for 30 days, and a telephone replay will be available through August 10, 2010, by dialing (800) 642-1687 (domestic) or (706) 645-9291 (international) and entering the conference ID number 90500390.

About AVANIR

AVANIR Pharmaceuticals, Inc. is a biopharmaceutical company focused on b
'/>"/>

SOURCE AVANIR Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Israel , Feb. 26, 2015 Integrity ... of the GlucoTrack ® model DF-F, a noninvasive  device ... Lutz Heinemann , Ph.D., will head its new ... opinion leaders in the field of Diabetes research, monitoring ... , Ph.D has been Chief Executive Officer and Head, ...
(Date:2/26/2015)... , Feb. 26, 2015  CSSi, ( www.CSSiEnroll.com ... the clinical research industry, is pleased to announce ... as a Project Manager, adding significant value and ... - http://photos.prnewswire.com/prnh/20150225/177750 Karen ... demonstrated ability to successfully lead the navigation of ...
(Date:2/26/2015)... Feb. 26, 2015  Technological advancements have ... effective, inexpensive and compact yet powerful solutions. ... small-scale, potent devices, lending momentum to the ... http://photos.prnewswire.com/prnh/20150225/177944LOGO New ... Nanomanufacturing, finds that nanomanufacturing will gain traction ...
Breaking Medicine Technology:Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 2Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 3Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 4CSSi's Continued Growth Brings Talented New Hire - Karen Welch Welcomed as Project Manager 2Revolutionary Nanomanufacturing Technology to Approach Commercialization by 2020 2Revolutionary Nanomanufacturing Technology to Approach Commercialization by 2020 3Revolutionary Nanomanufacturing Technology to Approach Commercialization by 2020 4
... Phase I data from XL880, Phase II data from ... SOUTH SAN FRANCISCO, May 30, 2007 /PRNewswire-FirstCall/ --,Exelixis, Inc. ... investigational compounds XL880 and XL999 will be,presented at the ... is being held June 1 to 5 in Chicago,Illinois. ...
... many as,first-line in secondary stroke prevention , ... presented today at the,16th European Stroke Conference in ... dipyridamole plus ASA,is marketed as Aggrenox® or Asasantin® ... vascular events in patients who had,a TIA or ...
Cached Medicine Technology:Six Abstracts Featuring Exelixis Compounds Accepted At ASCO,Conference 2New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 2New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 3New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 4
(Date:2/26/2015)... Los Angeles, CA (PRWEB) February 26, 2015 ... to live stream his hair transplant contest winner’s ... and preparation, the winner Marc R., is all set to ... transplant using the ARTAS system. His procedure will be done ... Parsa Mohebi website. To watch the surgery, go to the ...
(Date:2/26/2015)... Imagine a day without access to clean, ... and there was no one to help. For more than ... In 2015, more than 2.5 billion people will also lack ... A new initiative led by Nevada’s Desert Research Institute ... specifically on women – who often bear the brunt of ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 Thousands of ... step to fund powerful progress for the Muscular Dystrophy ... raising critical funds and awareness that will help save ... muscle disease. , “MDA Muscle Walk events unite and ... people whose abilities to move are compromised — including ...
(Date:2/26/2015)... 2015 Wound Care Advantage ... expanded its executive team by adding three key members ... the same time two WCA team members were promoted ... (WCA) was founded in 2002 and is one of ... The WCA team believes that providing outstanding patient care ...
(Date:2/26/2015)... PartnerTech Inc . has announced it has been named ... , The Movers & Makers Awards are presented in ... distribution of tangible products and will be held on March ... as Georgia’s largest local awards ceremony for manufacturing and supply ... local industry and business leaders. , “We are thrilled ...
Breaking Medicine News(10 mins):Health News:Hair Transplant Contest Winner’s Surgery to be Streamed LIVE 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 3Health News:MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease 2Health News:MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease 3Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 2Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 3Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 4Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 2Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 3
... in Sudan Called "Ground-breaking", DUBAI, United Arab ... billion last fall in an 8-week fundraising drive,Dubai ... the recipients of,its Phase One funding. Dubai Cares ... to improving primary education for,children in developing countries., ...
... of Energy,s Brookhaven National Laboratory have shown that increasing ... chemical, can reduce use of cocaine by 75 percent ... this team had similar findings for alcohol intake. Treatments ... receptors -- may prove useful in treating addiction, according ...
... supports hundreds of programs helping millions in the,developing ... WASHINGTON, April 16 The worldwide,pharmaceutical industry today ... biopharmaceutical companies, global,health leaders and policymakers together to ... developing world., Serving as a convening point ...
... The early use of magnetic resonance imaging (MRI) in ... a better adapted surgical approach to the tumour, a ... today (Wednesday April 16). Dr. David Martinez-Cecilia, a ... Rufian-Pea, in the Hospital Universitario Reina Sofia, Cordoba, Spain, ...
... 15 ECO2 Plastics, Inc.,(OTC Bulletin Board: ECOO), ... plastics are recycled, today reported its 2007 year-end,financial ... revenues of,$4.3 million for calendar year 2007 versus ... versus $14.9 million during the prior,year, with net ...
... to clamp the umbilical cord after a baby is born could ... comes with an increased risk of jaundice, according to a new ... seconds after birth is one of three steps in an active ... a new mother is vulnerable to excessive blood loss. Studies show ...
Cached Medicine News:Health News:Dubai Cares Announces 12 Country Plan to Educate and Empower Children in Developing Nations 2Health News:Dubai Cares Announces 12 Country Plan to Educate and Empower Children in Developing Nations 3Health News:Dubai Cares Announces 12 Country Plan to Educate and Empower Children in Developing Nations 4Health News:Gene therapy reduces cocaine use in rats 2Health News:Worldwide Pharmaceutical Industry Launches Global Health Progress Initiative to Expand Efforts to Improve Health in Developing Countries 2Health News:Worldwide Pharmaceutical Industry Launches Global Health Progress Initiative to Expand Efforts to Improve Health in Developing Countries 3Health News:MRI before surgery leads to better-adapted treatment for breast cancer 2Health News:ECO2 Plastics, Inc. Reports 2007 Year End Financial Results, Announces FDA Filing and Provides Outlook for 2008 2Health News:ECO2 Plastics, Inc. Reports 2007 Year End Financial Results, Announces FDA Filing and Provides Outlook for 2008 3Health News:Health risks, benefits come with delayed umbilical cord clamping 2
The Multi-Purpose Stand Magnifier is the most versatile stand magnifier. The stand has multiple configurations allowing for all situations where hands-free magnification is needed....
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Bausch & Lomb round and rectangular magnifiers incorporate precision optics and an ergonomic design for increased clarity and comfort during use...
Adjustable piston accommodates 7 - 9 mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9 mm trephine blades and 18 mm diameter Teflon block. Designed for accurate ...
Medicine Products: